Cargando…

Melanoma immunotherapy

Detalles Bibliográficos
Autores principales:	Garg, Abhishek D., Dudek-Peric, Aleksandra M., Agostinis, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671949/ https://www.ncbi.nlm.nih.gov/pubmed/26682274

Ejemplares similares

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
por: Garg, Abhishek D, et al.
Publicado: (2013)

Diversifying the platinum-based chemotherapy toolkit for immunogenic cancer cell death
por: Garg, Abhishek D., et al.
Publicado: (2020)

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
por: Dudek, Aleksandra M., et al.
Publicado: (2013)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
por: Romano, Erminia, et al.
Publicado: (2018)

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
por: Romano, Erminia, et al.
Publicado: (2018)

Immunology of Cell Death in Cancer Immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2021)

Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
por: Garg, Abhishek D., et al.
Publicado: (2016)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A
por: Garg, A D, et al.
Publicado: (2013)

PERK interacts with FLNA to regulate ER-PM contact sites
por: van Vliet, Alexander R., et al.
Publicado: (2017)

The emergence of phox-ER stress induced immunogenic apoptosis
por: Garg, Abhishek D., et al.
Publicado: (2012)

Drug-induced ciliogenesis in pancreatic cancer cells is facilitated by the secreted ATP-purinergic receptor signaling pathway
por: Khan, Niamat Ali, et al.
Publicado: (2017)

Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
por: Garg, Abhishek D, et al.
Publicado: (2014)

Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma
por: Demirsoy, Seyma, et al.
Publicado: (2016)

Considerations for adjuvant immunotherapy in stage II melanoma: KEYNOTE-716 and beyond
por: Chen, Lanyi Nora, et al.
Publicado: (2023)

Editorial of special focus on melanoma immunotherapy
por: Rossi, Ernesto
Publicado: (2022)

Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
por: Rutkowski, Piotr, et al.
Publicado: (2023)

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
por: Garg, Abhishek D., et al.
Publicado: (2015)

Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
por: Garg, Abhishek D., et al.
Publicado: (2018)

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Immunotherapy of melanoma
por: Haanen, John B.A.G.
Publicado: (2013)

Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
por: Van Woensel, Matthias, et al.
Publicado: (2017)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma
por: Vandenberk, Lien, et al.
Publicado: (2014)

Immunology of cell death in cancer and infection
por: Garg, Abhishek D.
Publicado: (2022)

The delicate balance of melanoma immunotherapy
por: Gyorki, David E, et al.
Publicado: (2013)

BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton
por: Maes, H, et al.
Publicado: (2014)

Immunotherapy in the management of melanoma: current status
por: Alston, Dylan, et al.
Publicado: (2013)

Cancer immunology and melanoma immunotherapy
por: Linck, Rudinei Diogo Marques, et al.
Publicado: (2017)

The age of enlightenment in melanoma immunotherapy
por: Albertini, Mark R.
Publicado: (2018)

The use of immunotherapy in the treatment of melanoma
por: Achkar, Tala, et al.
Publicado: (2017)

Current application of immunotherapy in melanoma
por: Xie, Ruxin, et al.
Publicado: (2023)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Advances in Stem Cell Immunotherapy
por: Anderson, Johnathon D
Publicado: (2023)

Cancer immunotherapy
por: Yan, Li, et al.
Publicado: (2014)

The immunotherapy prize!
por: Delamarre, Lélia
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dg42raahovou52sml078l1398o